Secondary analysis of 529 people with progressive MS in the placebo-controlled SPI2 trial of MD1003: higher EDSS and slower T25FW were linked to lower minute-level step counts, especially mid-day; ambulation, pyramidal and cerebellar scores explained most variation.
Secondary analysisn = 529
Behal et al. Diurnal step count patterns in progressive multiple sclerosis